An innovative approach to determine fetal risk: the FDA Office of Women's Health pregnancy exposure registry web listing.
Sharma
Pellavi
P
Food and Drug Administration, Office of Women's Health, Rockville, Maryland, USA. pellavi.sharma@fda.hhs.gov
Parekh
Ameeta
A
Uhl
Kathleen
K
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000328:Adult; D005260:Female; D006291:Health Policy; D006801:Humans; D020407:Internet / Q000331:legislation & jurisprudence*; D018811:Maternal Exposure / Q000517:prevention & control; D011247:Pregnancy; D011295:Prenatal Care / Q000331:legislation & jurisprudence; D011296:Prenatal Diagnosis / Q000379:methods*; D011297:Prenatal Exposure Delayed Effects / Q000517:prevention & control*; D012042:Registries; D014481:United States; D014486:United States Food and Drug Administration